Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

SODIUM HYPOCHLORITE SO

Active
SPE2DP-26-T-4202Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Sodium hypochlorite solution, modified at 0.125 percent strength, is being procured in 480 milliliter (16 oz) bottles under the part number NDC00436-0672-16 by Century Pharmaceuticals Inc for use as a medical disinfectant. The item is classified as a FDA-regulated drug with a strict 12-month non-extendable shelf life and must be stored at controlled room temperature. Packaging and marking must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all shipments must comply with DLA packaging requirements and hazardous materials handling guidelines. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest rate. The delivery is FOB destination with zero variance allowed and must be completed within 20 days of contract award, with inspection and acceptance occurring at the delivery point. The destination is the USNS MERCY medical treatment facility, and traceable freight shipping is required—parcel post is prohibited. The NSN is 6505015887606, and the solicitation number is SPE2DP-26-T-4202 with a response deadline of July 27, 2026 and a required delivery date of July 20, 2026. All bidders must provide source and part number details and comply with DLA’s master list of technical and quality requirements, including those referenced under RS011, RA001, RP001, and RQ011. The contract also includes covered defense information provisions and requires adherence to specific labeling and shipment standards.

General Info

Sodium hypochlorite 0.125% in 480mL bottles, FDA-regulated, 12-month shelf life, FOB destination, deliver to USNS MERCY by July 20, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4202 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
SODIUM HYPOCHLORITE SOLUTION
SODIUM HYPOCHLORITE SOLUTION, MODIFIED
0.125 PCT, DAKINS SOLUTION QUARTER
STRENGTH, 480 ML (16 OZ) BOTTLE
.
STORE AT CONTROLLED ROOM TEMPERATURE,
.
1 BT = 16 OZ
RS011: Shelf-life requirement RS001 for a TYPE I (CODE H) item with a shelf life of 12 months (non-extendable) applies to this item.
. RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. BIDDER SHALL SPECIFY SOURCE AND PART NUMBER BEING SUPPLIED. . This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES . MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
CENTURY PHARMACEUTICALS INC 54002 P/N NDC00436-0672-16
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4202
SECTION B
PR: 7017515313 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017515313 0001 BT 1.000
NSN/MATERIAL:6505015887606
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
SPE2DP-26-T-4202
SECTION B
PR: 7017515313 PRLI: 0001 CONT’D
N46245
MEDICAL TREATMENT FACILITY
USNS MERCY T AH 19
FPO AP 96672-4090
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N46245
MED TREATMENT FAC USNS MERCY T AH 1
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N4624561964239
RDD:
PROJ: TP 3
SUPP ADD: 784000 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:07/20/2026
SPE2DP-26-T-4202 NSN/Part Number: 6505-01-588-7606 Quantity: 1 BT Purchase Request: 7017515313QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Medical Chemical Formulation and ManufacturingThe contract involves the manufacture of a modified 0.125 percent sodium hypochlorite solution, known as Dakins Solution Quarter Strength, packaged in 480 mL bottles. The scope includes full formulation development, rigorous quality control protocols, batch-by-batch testing to ensure consistency and safety, and strict compliance with medical-grade standards to meet regulatory requirements for clinical use. All production activities must adhere to guidelines ensuring sterility, stability, and purity, as the final product is intended for medical applications requiring precise chemical concentrations and contamination-free packaging. The contract is classified as a subcontract under NAICS code 325412 for pharmaceutical and medicine manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. It was posted on July 20, 2026, with a response deadline of July 27, 2026, and the performance location is not specified, implying flexibility in manufacturing site selection as long as compliance and delivery standards are met. The solicitation is accessible through the DIBBS platform, and while no set-aside provisions or point of contact information is provided, bidders are expected to demonstrate proven capability in producing pharmaceutical-grade chemical solutions with validated quality systems and documented adherence to medical manufacturing regulations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency